Skip to main content
Caplight Logo









RAYDIAX

RAYDIAX

Private
MagdeburgHealthcare & Life Scienceshttps://raydiax.com/

Last Round

Grant

Mar 1, 2026

Total Funding Raised

$6.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RAYDIAX is a medical technology company that develops a therapy-assistance computed tomography (CT) system for minimally invasive cancer interventions.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

interventional imagingmedical deviceimage-guided surgerycomputed tomographyCTminimally invasive surgeryinterventional radiologytherapy assistancemedical imaging platformrobotic integrationsurgical navigationmedtechinterventional suiteprocedural guidancemedical hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RAYDIAX Comparables

Compare RAYDIAX with similar companies based on industry and business-model similarity.

RAYDIAX comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Epica International, Inc.
78%
GE HealthCare Technologies Inc.
74%
Philips
74%

RAYDIAX Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2026
SeedOct 26, 2023
GrantOct 26, 2023

Key People

Founding team and executive leadership

Thomas Hoffmann

CEO Co-Founder

Founding Team

Roy Rothenberg

Chief Financial Officer EXIST Research Transfer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 10, 2026

    Open roles increased to 5, representing 25% of headcount.

RAYDIAX Filings

Explore SEC and related filing metadata, where available.

RAYDIAX filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RAYDIAX's valuation, stock price, and market status.

Is RAYDIAX a public or private company?

RAYDIAX is a private company.

What is the current stock price of RAYDIAX?

RAYDIAX is a private company with no public stock price. No recent secondary market data is available.

How much is RAYDIAX worth (valuation)?

Valuation information for RAYDIAX is not publicly available.

Can I buy RAYDIAX stock?

RAYDIAX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RAYDIAX's last funding round?

RAYDIAX's most recent funding round was Grant on March 4, 2026.

Who are the main investors in RAYDIAX?

Key investors in RAYDIAX include High-Tech Gründerfonds.

Will RAYDIAX IPO soon?

No public IPO plans have been announced for RAYDIAX.

How can I track RAYDIAX secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RAYDIAX's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMagdeburg
Employee Range20
Year Founded2022
Last FundingMar 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?